HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A double-blind study to determine the maximum tolerated dose of ethionamide, when administered twice-weekly to patients with pulmonary tuberculosis.

AuthorsS Devadatta, N K Menon, O Nazareth, S Radhakrishna, C V Ramakrishnan, P R Somasundaram, S P Usha, S Velu
JournalTubercle (Tubercle) Vol. 51 Issue 3 Pg. 263-9 (Sep 1970) ISSN: 0041-3879 [Print] Scotland
PMID4924649 (Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article)
Chemical References
  • Aminosalicylic Acids
  • Ethionamide
Topics
  • Age Factors
  • Aminosalicylic Acids (therapeutic use)
  • Body Weight
  • Clinical Trials as Topic
  • Ethionamide (administration & dosage, adverse effects)
  • Female
  • Humans
  • Male
  • Sex Factors
  • Tuberculosis, Pulmonary (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: